iCELLis™ Single-Use Fixed-Bed Bioreactor Systems
Source: Cytiva
The iCELLis™ bioreactor system is an automated, single-use, fixed-bed bioreactor that provides excellent cell growth conditions for adherent cells.
Available in three formats, they deliver scalable performance from 0.5 to 500 m2, empowering you to move from R&D to GMP manufacturing faster and more efficiently than ever before.
Meet the iCELLis™ bioreactor family:
- The iCELLis™ Nano system for process development and small-scale production (0.5 to 4 m2)
- The iCELLis™ 50 system for pilot-scale process development and medium-scale clinical manufacturing (6 to 50 m2)
- The iCELLis™ 500+ system for industrial scale manufacturing (66 to 500 m2)
Why iCELLis™ bioreactors?
- Proven performance: used in 6 approved therapies, including Zolgensma for treatment of spinal muscular atrophy
- Scalable innovation: seamless scale-up from 0.5 to 500 m2 in a single platform
- GMP-readiness: closed single-use system, 21 CFR Part 11 compliant software that has undergone 100+ hours of user testing to optimize ease-of-use
- Versatility: 90+ publications demonstrating successful production of AAV, Lentivirus, oncolytic virus, exosomes, human vaccines, and more
Accelerate your gene therapy pipeline with iCELLis™ bioreactors.